Hackers Targeting 59 Banking, Fintech and Crypto Platforms, Stealing Credentials, PINs and More: Report The Daily Hodl
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
